GWAS-related meQTLs across different cancer types
We identified 2,214,458 meQTLs that overlap with GWAS linkage disequilibrium (LD) regions (r² ≥ 0.5).
Cancer type
|
QTL type
|
tagSNP
|
Gene position (hg19)
|
Gene
|
p-value
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BLCA | cis | rs1790761 | 0.692 | rs1269981 | chr11:67334959 | G/A | cg08355456 | chr11:67383691 | NA | 0.33 | 6.23 | 0.3 | 1.26E-9 | Mean corpuscular volume; |
BLCA | cis | rs11229555 | 0.645 | rs12797488 | chr11:58174653 | A/T | cg15696309 | chr11:58395628 | NA | -0.55 | -6.67 | -0.32 | 8.87E-11 | Ulcerative colitis;Inflammatory bowel disease;Crohn's disease; |
BLCA | cis | rs6570726 | 0.791 | rs1280275 | chr6:145892402 | C/T | cg23711669 | chr6:146136114 | FBXO30 | 0.86 | 16.75 | 0.65 | 1.51E-47 | Lobe attachment (rater-scored or self-reported); |
BLCA | cis | rs1545257 | 0.537 | rs12988283 | chr2:24642086 | G/C | cg06627628 | chr2:24431161 | ITSN2 | -0.43 | -6.49 | -0.32 | 2.64E-10 | Sjögren's syndrome; |
BLCA | cis | rs13108904 | 0.934 | rs13134106 | chr4:1302902 | A/G | cg13395646 | chr4:1353034 | KIAA1530 | -0.71 | -11.85 | -0.52 | 8.84E-28 | Obesity-related traits; |
BLCA | cis | rs9611565 | 0.765 | rs132920 | chr22:41810170 | T/C | cg17376030 | chr22:41985996 | PMM1 | -0.5 | -7.07 | -0.34 | 7.43E-12 | Vitiligo; |
BLCA | cis | rs823143 | 0.57 | rs1361754 | chr1:205801872 | C/T | cg11965913 | chr1:205819406 | PM20D1 | -0.71 | -14.14 | -0.59 | 9.45E-37 | Monocyte percentage of white cells; |
BLCA | cis | rs8060686 | 0.641 | rs13816 | chr16:68055495 | G/C | cg09835421 | chr16:68378352 | PRMT7 | -0.56 | -6.95 | -0.34 | 1.59E-11 | HDL cholesterol;Metabolic syndrome; |
BLCA | cis | rs9790314 | 1 | rs1382426 | chr3:161045933 | G/A | cg03342759 | chr3:160939853 | NMD3 | -0.64 | -9.79 | -0.45 | 2.53E-20 | Morning vs. evening chronotype; |
BLCA | cis | rs1003719 | 0.788 | rs1543749 | chr21:38446621 | A/G | cg10648535 | chr21:38446584 | PIGP;TTC3 | 0.69 | 12.16 | 0.53 | 5.84E-29 | Eye color traits; |
BLCA | cis | rs12586317 | 0.534 | rs1568200 | chr14:35419592 | C/T | cg16230307 | chr14:35515116 | FAM177A1 | 0.75 | 10.41 | 0.47 | 1.65E-22 | Psoriasis; |
BLCA | cis | rs317689 | 0.581 | rs160829 | chr12:69769538 | G/C | cg20891283 | chr12:69753455 | YEATS4 | 0.56 | 8.16 | 0.39 | 5.11E-15 | Response to diuretic therapy; |
BLCA | cis | rs10876993 | 0.928 | rs1689595 | chr12:58056763 | C/T | cg18357645 | chr12:58087776 | OS9 | 0.53 | 8.44 | 0.4 | 6.54E-16 | Celiac disease or Rheumatoid arthritis; |
BLCA | cis | rs7246967 | 0.673 | rs16999580 | chr19:22923487 | C/T | cg23217946 | chr19:22817039 | ZNF492 | 0.53 | 6.75 | 0.33 | 5.42E-11 | Bronchopulmonary dysplasia; |
BLCA | cis | rs10504229 | 1 | rs17805326 | chr8:58169533 | A/C | cg24829409 | chr8:58192753 | C8orf71 | -0.43 | -6.88 | -0.33 | 2.5E-11 | Developmental language disorder (linguistic errors); |